Table I.
Tumor Cell Line | GM-CSF | IFN-γ | Tumor Cell Line | GM-CSF | IFN-γ |
---|---|---|---|---|---|
Breast cancer | Melanoma | ||||
BT474 | 0 | 0 | 1312 | 0 | 0 |
MCF-7 | 0 | 0 | 1338 | 0 | 0 |
SKOV3 | 0 | 0 | 501A | 0 | 0 |
MB361 | 4 | 0 | 1143 | 0 | 0 |
BT549 | 5 | 0 | 537 | 0 | 0 |
MDA231 | 668 | 0 | 1353 | 0 | 0 |
553B | 0 | 0 | |||
Cervical cancer | 677II | 0 | 0 | ||
MS751 | 0 | 0 | 1173 | 0 | 0 |
SIHA | 16 | 0 | 1402 | 0 | 0 |
CASKI | 488 | 12 | 1290−2 | 0 | 0 |
1199 | 0 | 0 | |||
Ovarian cancer | 888 | 0 | 0 | ||
IGROV-1 | 0 | 0 | 1287 | 0 | 0 |
OVCAR-3 | 0 | 0 | 1011 | 0 | 0 |
OV-1 | 17 | 0 | 624 | 0 | 0 |
1359 | 0 | 0 | |||
Prostate cancer | 1363 | 0 | 0 | ||
LNCaP | 0 | 0 | 1495 | 0 | 0 |
Du 145 | 45 | 0 | 1280−1 | 0 | 0 |
PC 3 270.4 | 270 | 0 | 697 | 0 | 0 |
1542 CP3 | 1,035 | 0 | 1362 | 0 | 0 |
Tx | |||||
526 | 0 | 0 | |||
Colon cancer | 1308 | 0 | 0 | ||
WIDR | 0 | 0 | 1335 | 0 | 0 |
H508 | 3 | 0 | 586 | 0 | 0 |
COLO 205 | 7 | 0 | 1182 | 0 | 0 |
SW480 | 34 | 16 | 1479 | 0 | 0 |
LOVO | 36 | 0 | 1102 | 0 | 0 |
836 | 0 | 0 | |||
Renal cancer | 938 | 0 | 0 | ||
Ce-RCC | 0 | 0 | 1379 | 0 | 0 |
M-RCC | 25 | 0 | SK23 | 0 | 0 |
Gr-RCC | 29 | 0 | 624 | 0 | 0 |
R-RCC | 98 | 0 | 883 | 0 | 0 |
Ca-RCC | 125 | 0 | 1286 | 0 | 0 |
Gi-RCC | 675 | 0 | 397 | 4 | 0 |
N-RCC | 1,125 | 120 | 1123 | 30 | 0 |
P-RCC | 1,134 | 0 | 1390 | 43 | 0 |
Ba-RCC | 1,723 | 0 | 1448Y | 277 | 0 |
Bu-RCC | 1,707 | 0 | 1195 | 280 | 0 |
W-RCC | 39,390 | 0 |
Values are expressed as picograms/ml produced in 16 h by 105 cells. Values for culture media alone were <12 pg/ml for IFN-γ and 2 pg/ml for GM-CSF. All values were obtained from duplicate samples.